| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Neurology, Aarhus University Hospital (Drs. Christensen, Jensen, and de Fine Olivarius), Aarhus; Odense University Hospital (Dr. Tsiropoulos), Odense; Viborg Hospital (Dr. Søsrensen), Viborg; Holstebro Hospital (Dr. Kjær), Holstebro; Vejle Hospital (Dr. Høsjer-Pedersen), Vejle; Sønderborg Hospital (Dr. Rasmussen), Sønderborg; and Esbjerg Hospital (Dr. Lehfeldt), Esbjerg, Denmark.
We studied the epidemiology of myasthenia gravis (MG) in western Denmark from 1975 to 1989, basing case identification on records from all hospitals in the survey area. The population surveyed was 2.80 million in 1985. The average annual incidence rate was 5.0 per million population (women, 5.9; men, 4.2). The point-prevalence rate (January 1, 1990) was 78 per million population (women, 102; men, 53). In men, the incidence increased after 40 years. In women, the incidence rates showed a bimodal pattern with a peak of 7.0 in the age group 20 to 29 years and a second peak of 11.7 in the age group 70 to 79 years. The differences in sex- and age-specific incidence rates suggest that younger women are more susceptible to MG than younger men. Old men and postmenopausal women had similar rates. When last examined, 21% of the 220 prevalent cases were in remission and 18% were moderately or severely disabled.
Address correspondence and reprint requests to Dr. Peter Brøgger Christensen, Department of Neurology, Aarhus University Hospital, Aarhus Kommunehospital, 8000 Aarhus, Denmark.
Received May 1, 1992. Accepted for publication in final form January 12, 1993.
This article has been cited by other articles:
|
|
 |
|
  A. T. Heldal, J. F. Owe, N. E. Gilhus, and F. Romi SEROPOSITIVE MYASTHENIA GRAVIS: A NATIONWIDE EPIDEMIOLOGIC STUDY Neurology, July 14, 2009; 73(2): 150 - 151. [Full Text] [PDF]
|
|
|
|
|
|
A. Alshekhlee, J. D. Miles, B. Katirji, D. C. Preston, and H. J. Kaminski Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals Neurology, May 5, 2009; 72(18): 1548 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Oopik, A-E Kaasik, and J Jakobsen A population based epidemiological study on myasthenia gravis in Estonia J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(12): 1638 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Aragones, I. Bolibar, X. Bonfill, E. Bufill, A. Mummany, F. Alonso, and I. Illa Myasthenia gravis: A higher than expected incidence in the elderly Neurology, March 25, 2003; 60(6): 1024 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Haliloglu, B. Anlar, S. Aysun, M. Topcu, H. Topaloglu, G. Turanli, and D. Yalnizoglu Gender Prevalence in Childhood Multiple Sclerosis and Myasthenia Gravis J Child Neurol, May 1, 2002; 17(5): 390 - 392. [Abstract] [PDF]
|
|
|
|
|
|
K Poulas, E Tsibri, A Kokla, D Papanastasiou, T Tsouloufis, M Marinou, P Tsantili, T Papapetropoulos, and S J Tzartos Epidemiology of seropositive myasthenia gravis in Greece J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 352 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. MacDonald, O. C. Cockerell, J. W. A. S. Sander, and S. D. Shorvon The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK Brain, April 1, 2000; 123(4): 665 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Aarli Late-Onset Myasthenia Gravis: A Changing Scene Arch Neurol, January 1, 1999; 56(1): 25 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P B Christensen, T S Jensen, I Tsiropoulos, T Sørensen, M Kjær, E Højer-Pedersen, M J K Rasmussen, and E Lehfeldt Mortality and survival in myasthenia gravis: a Danish population based study J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 78 - 83. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
